Ever since the discovery of the involvement of tyrosine kinases (TK) in cancer, which led to their consideration as valuable targets for cancer treatment, a broad spectrum of TKis has been launched, including Bruton’s tyrosine kinase inhibitors (BTKis). The gene discussed is TKT; the disease is cancer.